<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03667274</url>
  </required_header>
  <id_info>
    <org_study_id>2018-00553; ch18Grapow2</org_study_id>
    <nct_id>NCT03667274</nct_id>
  </id_info>
  <brief_title>Patient Outcome After Cardiac Double Valve Replacement at University Hospital Basel/ Switzerland</brief_title>
  <official_title>Patient Outcome After Cardiac Double Valve Replacement at University Hospital Basel/ Switzerland</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare patient outcome data after cardiac double valve replacement (aortic and mitral
      valve) with patient outcome data after aortic valve replacement and mitral valve
      reconstruction
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To compare patient outcome data ( death, re-surgery, change in transvalvular gradient) after
      cardiac double valve replacement (aortic and mitral valve) with patient outcome data after
      aortic valve replacement and mitral valve reconstruction in patients with cardiac surgery at
      University Hospital Basel/ Switzerland since 2009.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>death</measure>
    <time_frame>time from hospitalisation for cardiac valve surgery and following 12 months</time_frame>
    <description>death after cardiac valve surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>re-surgery</measure>
    <time_frame>time from hospitalisation for cardiac valve surgery and following 12 months</time_frame>
    <description>re-surgery after cardiac valve surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>change in transvalvular gradient</measure>
    <time_frame>time from hospitalisation for cardiac valve surgery and following 12 months</time_frame>
    <description>change in transvalvular Gradient after cardiac valve surgery</description>
  </primary_outcome>
  <enrollment type="Actual">106</enrollment>
  <condition>Cardiac Double Valve Replacement</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>cardiac valve surgery</intervention_name>
    <description>cardiac double valve surgery (aortic and mitral valve)</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients undergoing cardiac double valve surgery (aortic valve replacement, mitral valve
        replacement, mitral valve reconstruction) at University Hospital Basel/ Switzerland,
        starting 2009
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing cardiac double valve surgery (aortic valve replacement, mitral
             valve replacement, mitral valve reconstruction) at University Hospital Basel/
             Switzerland, starting 2009

        Exclusion Criteria:

          -  denial of consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Grapow, Prof. Dr. MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Basel, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Herzchirurgie University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>September 10, 2018</study_first_submitted>
  <study_first_submitted_qc>September 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 12, 2018</study_first_posted>
  <last_update_submitted>April 14, 2020</last_update_submitted>
  <last_update_submitted_qc>April 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 15, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>aortic valve replacement</keyword>
  <keyword>mitral valve reconstruction</keyword>
  <keyword>mitral valve replacement</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

